Literature DB >> 9770145

Diarrhea and Clostridium difficile infection in Latin American patients with AIDS. Working Group on AIDS in Peru.

F F Willingham1, E Ticona Chavez, D N Taylor, A B Bowen, A R Crane, A L Gottlieb, M K Gayles, K F Grahn, V M Chavez Perez, I Salas Apolinario, R H Gilman.   

Abstract

Diarrhea and wasting are among the most debilitating and deadly manifestations of AIDS, yet only limited information is available regarding the etiology, clinical consequences, and immunologic effects of infection with diarrheal agents. Peruvian AIDS patients presenting with and without diarrhea were followed prospectively to examine the relations among diarrheal pathogens, clinical presentations, CD4 lymphocyte count, weight loss, and survival. Patients with chronic diarrhea had lower CD4 lymphocyte counts (P = .001) and lost more weight (P < .001). Weight loss and a decreased CD4 lymphocyte count were associated with increased mortality (P = .011 and P = .003, respectively). Mean CD4 lymphocyte count varied significantly by diarrheal agent. Clostridium difficile was the most prevalent pathogen and was associated with significantly increased mortality before and after adjustment for coinfection, length of follow-up, CD4 lymphocyte count, and weight loss (P = .006). C. difficile may be a more important and more prevalent etiologic agent in AIDS than previously recognized and may represent a preventable cause of death in patients with immunosuppression.

Entities:  

Mesh:

Year:  1998        PMID: 9770145     DOI: 10.1086/514688

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  6 in total

1.  Postmortem findings and opportunistic infections in HIV-positive patients from a public hospital in Peru.

Authors:  Dominique Eza; Gustavo Cerrillo; David A J Moore; Cecilia Castro; Eduardo Ticona; Domingo Morales; Jose Cabanillas; Fernando Barrantes; Alejandro Alfaro; Alejandro Benavides; Arturo Rafael; Gilberto Valladares; Fernando Arevalo; Carlton A Evans; Robert H Gilman
Journal:  Pathol Res Pract       Date:  2006-09-19       Impact factor: 3.250

Review 2.  Clostridium difficile infection in patients with HIV/AIDS.

Authors:  Paul J Collini; Ed Kuijper; David H Dockrell
Journal:  Curr HIV/AIDS Rep       Date:  2013-09       Impact factor: 5.071

Review 3.  Avoiding pitfalls: what an endoscopist should know in liver transplantation--part II.

Authors:  Sharad Sharma; Ahmet Gurakar; Cemalettin Camci; Nicolas Jabbour
Journal:  Dig Dis Sci       Date:  2008-12-17       Impact factor: 3.199

4.  Clostridium difficile-associated diarrhea after living donor liver transplantation.

Authors:  Masao Hashimoto; Yasuhiko Sugawara; Sumihito Tamura; Junichi Kaneko; Yuichi Matsui; Junichi Togashi; Masatoshi Makuuch
Journal:  World J Gastroenterol       Date:  2007-04-14       Impact factor: 5.742

5.  Clostridium difficile in a HIV-infected cohort: incidence, risk factors, and clinical outcomes.

Authors:  Charles F Haines; Richard D Moore; John G Bartlett; Cynthia L Sears; Sara E Cosgrove; Karen Carroll; Kelly A Gebo
Journal:  AIDS       Date:  2013-11-13       Impact factor: 4.177

6.  Presentation of COVID-19 in a liver transplant recipient.

Authors:  Behzad Hatami; Pardis Ketabi Moghadam; Mohammadreza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2020
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.